Liver transplantation in a patient after COVID‐19 – Rapid loss of antibodies and prolonged viral RNA shedding

To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS‐CoV‐2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID‐19. Here, we report on a successful liver transplantation shortly after convalescence from COVID‐19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA. The authors report successful liver transplantation shortly after recovery from COVID‐19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.